Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents

Author(s): K. Augustyns , K. Amssoms , A. Yamani , P. K. Rajan , A. Haemers .

Journal Name: Current Pharmaceutical Design

Volume 7 , Issue 12 , 2001

Abstract:

Trypanothione is the key molecule in the defence mechanism of Trypanosoma and Leishmania against oxidative stress. The uniqueness of trypanothione makes the metabolism of this molecule an attractive target in antitrypanosomal and antileishmanial drug design. It became clear that this antioxidant cascade can be considered as the Achilles heel of these parasites. The following targets and their respective inhibitors will be discussed biosynthesis of trypanothione with glutathionylspermidine synthetase and trypanothione synthetase biosynthesis of glutathione with gama-glutamylcysteine synthetase biosynthesis of spermidine with ornithine decarboxylase trypanothione hydroperoxide metabolism with tryparedoxine peroxidase, tryparedoxine and trypanothione reductase.

Keywords: Trypanothione, Antitrypanosomal, Antileishmanial Agents, oxidative stress, glutathionylspermidine synthetase, trypanothione synthetase, g-glutamylcysteine, spermidine, ornithine, decarboxylase

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 12
Year: 2001
Page: [1117 - 1141]
Pages: 25
DOI: 10.2174/1381612013397564
Price: $58

Article Metrics

PDF: 12